| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/12/2008 | CN101139589A Preparation method of immortalized cell for expression of infectious bursal virus VP2 gene encoding protein |
| 03/12/2008 | CN101139394A Cytoplasma membrane surface antigen monoclonal antibody and uses thereof |
| 03/12/2008 | CN101139393A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101139392A KDR peptides and vaccines containing the same |
| 03/12/2008 | CN101138633A BCG vaccine for preventing and reversing fleshy and fleshy cardiovascular organization |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374552C Method of large scale production of hepatitis a virus |
| 03/12/2008 | CN100374548C BCG vaccine strain of recombined interferon and its preparation process |
| 03/12/2008 | CN100374466C Antibodies against human IL-12 |
| 03/12/2008 | CN100374465C Neutralizing antibodies against GDF-8 and uses therefor |
| 03/12/2008 | CN100374464C Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 03/12/2008 | CN100374457C Anti-IL-6 antibodies, compositions, methods and uses |
| 03/12/2008 | CN100374456C Specific human antibodies for selective cancer therapy |
| 03/12/2008 | CN100374159C Preventives or remedies for inflammatory intestinal diseases contg. as active ingredient IL-6 antagonists |
| 03/12/2008 | CN100374152C Hypersensitivity reaction inhibitor |
| 03/12/2008 | CN100374151C medicine compositions for generating immune and usage of prevention and treatment of amyloidogenic disease |
| 03/11/2008 | US7342110 Polynucleotides, host cells and vectors for antibodies against leukemia CD 33 antigen |
| 03/11/2008 | US7342107 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
| 03/11/2008 | US7342103 Comprises DNAX interferon-like receptor subunit (DIRS) polypeptide for use in diagnosis and treatment of inflammation and blood disorders |
| 03/11/2008 | US7342101 Immunization against Coccidioides spp. fungi, protein and peptide antigens |
| 03/11/2008 | US7342094 Tumor vaccines for MUC1-positive carcinomas |
| 03/11/2008 | US7342091 Soluble cyclic analogues of β amyloid peptide |
| 03/11/2008 | US7342090 Peptide-mimetics are constrained in the three-dimensional structure to provide an increased immunogenicity to the epitope sequence |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | US7341994 to structurally mimic GD3, which are known as tumor associated antigens found in tumors such as melanoma; vaccine; i.e., a carcinostatic effect and an inhibitory effect for cancerous metastasis |
| 03/11/2008 | US7341988 Method of treating influenza with geranyl-geranyl acetone |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341866 Gene expression patterns; diagnosis, therapy disease |
| 03/11/2008 | US7341860 Regulated antigen delivery system (RADS) |
| 03/11/2008 | US7341829 Medical diagnosis; detecting parasites |
| 03/11/2008 | US7341733 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient |
| 03/11/2008 | US7341732 Methods for treating mastitis in a milk producing animal |
| 03/11/2008 | US7341731 HIV-2 antigen compositions |
| 03/11/2008 | US7341730 Inhibitors of angiogenesis and tumor growth |
| 03/11/2008 | US7341729 Recombinant parainfluenza virus expression systems and vaccines |
| 03/11/2008 | US7341728 Internalisation of virus into cells |
| 03/11/2008 | US7341727 M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| 03/11/2008 | US7341726 Modified HCV peptide immunogens |
| 03/11/2008 | US7341725 Structural proteins of fish pancreatic disease virus and uses thereof |
| 03/11/2008 | US7341724 Apoptosis of rectum and prostate gland cancer |
| 03/11/2008 | US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
| 03/11/2008 | US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 03/11/2008 | US7341710 Method of identifying molecules that home to a selected organ in vivo |
| 03/11/2008 | CA2391647C Biomolecular complex formed between hyaluronic acid and a biomolecule |
| 03/11/2008 | CA2358022C Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 03/11/2008 | CA2300358C Novel phytase |
| 03/11/2008 | CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 03/11/2008 | CA2270396C Cationic reagents for transfection |
| 03/11/2008 | CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 03/08/2008 | CA2601358A1 Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
| 03/06/2008 | WO2008028192A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/06/2008 | WO2008028117A2 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 03/06/2008 | WO2008027800A2 Method for enhancing the efficacy of antigen specific tumor immunotherapy |
| 03/06/2008 | WO2008027394A2 Constructs for enhancing immune responses |
| 03/06/2008 | WO2008027377A1 Compositions and methods for inhibition of influenza virus- induced pulmonary immune pathology |
| 03/06/2008 | WO2008027238A2 Induction of immunosuppression by inhibition of atm |
| 03/06/2008 | WO2008027235A1 Methods and compositions for control of disease in aquaculture |
| 03/06/2008 | WO2008027084A2 Modified aav vectors having reduced capsid immunogenicity and use thereof |
| 03/06/2008 | WO2008027013A2 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer |
| 03/06/2008 | WO2008026781A1 Reverse targeting lipid vesicle |
| 03/06/2008 | WO2008026720A1 Antibody capable of enhancing activation of blood coagulation factor viii |
| 03/06/2008 | WO2008026603A1 Anti-tumor agent |
| 03/06/2008 | WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT |
| 03/06/2008 | WO2008026225A2 A vaccine for chikungunya virus infection |
| 03/06/2008 | WO2008026071A2 Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens |
| 03/06/2008 | WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas |
| 03/06/2008 | WO2008025848A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 03/06/2008 | WO2008025843A1 Viral adjuvants |
| 03/06/2008 | WO2008025171A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | WO2008025099A1 Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
| 03/06/2008 | WO2008025095A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | WO2007149566A3 Viral sequences and uses thereof |
| 03/06/2008 | WO2007147518A3 Use of ppd for the adjuvantation of a nucleic acid vaccine |
| 03/06/2008 | WO2007143711A3 Blood-brain barrier targeting antibodies |
| 03/06/2008 | WO2007136789A3 Methods of preventing, treating or ameliorating enhanced respiratory disease via innate immune mechanisms |
| 03/06/2008 | WO2007134132A3 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 03/06/2008 | WO2007131242A3 Streptavidin-biotin-link antibody-hapten system |
| 03/06/2008 | WO2007130330A3 Polyvalent influenza virus-like particle (vlp) compositions |
| 03/06/2008 | WO2007123850A3 Recombinant attenuated clostridium organisms and vaccine |
| 03/06/2008 | WO2007121184A9 Compounds and methods for diagnosis and treatment of leishmaniasis |
| 03/06/2008 | WO2007119011A3 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 03/06/2008 | WO2007112518A8 Live attenuated salmonella vaccine |
| 03/06/2008 | WO2007109749A3 Methods for preventing and treating amyloidogenic diseases |
| 03/06/2008 | WO2007100643A3 Methods of using antibodies against human il-22 |
| 03/06/2008 | WO2007100607A3 Immunogenic peptides and methods of use |
| 03/06/2008 | WO2007087412A3 Tat-036 and methods of assessing and treating cancer |
| 03/06/2008 | WO2007080404A3 Leptin ligand |
| 03/06/2008 | WO2007075270A3 Multivalent immunoglobulin-based bioactive assemblies |
| 03/06/2008 | WO2006120473A3 Mhc class i and ii peptide antigens derived from tumour antigen 5t4 |
| 03/06/2008 | WO2006118772A9 Fcrn antibodies and uses thereof |
| 03/06/2008 | WO2006117586A8 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 03/06/2008 | WO2006089264A8 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| 03/06/2008 | WO2003076568A3 Immunotherapeutics for biodefense |
| 03/06/2008 | WO2001040439A3 CLONING AND EXPRESSION OF A DNA SEQUENCE ENCODING A 41 kDa CRYPTOSPORIDIUM PARVUM OOCYST WALL PROTEIN |
| 03/06/2008 | US20080058762 Induction And Maintenance Of Tolerance To Composite Tissue Allografts |
| 03/06/2008 | US20080058507 Using bind elute process to isolate preferential immunoglobulin components; antibody purification |
| 03/06/2008 | US20080058429 Diagnosis Of Primary Open Angle Glaucoma |